Tendulkar dedicates his 44th ODI century to Dungarpur

Mumbai, Sep. 16 (ANI): Condoling the death of former BCCI chairmen Raj Singh Dungarpur, master blaster Sachin Tendulkar dedicated his 44th ODI century to the man who selected him for international cricket in 1989.

“Wherever Rajbhai is he was definitely watching us yesterday and feeling happy for Indian team for having won yesterday. I’d like to take this opportunity to say that yesterday’s 100 was for Raj Bhai. We miss you Rajbhai,” Tendulkar said.

Dungarpur, 73, was suffering from Alzheimer’s and had died on Saturday.

Dugarpur belonged to the Dungarpur royal family and also played first class cricket for Rajasthan.

Tendulkar urged officials of Cricket Club of India, where Dungarpur played and also presided as president for almost a decade and a half, to name one of its gate after him.

“I know that here, CCI have named rooms after the ex-cricketers, the library is also named after a cricketer. Just like Prof. Shetty, I would like to request the management of CCI, I think the appropriate thing to do would be to name the main gate after Rajbhai because that is where I think is the right place for Rajbhai and I would strongly urge that,” said Tendulkar.

Veteran cricketers, Bapu Nadkarni, Dilip Vengsarkar, Sandeep Patil, Karsan Ghavri, Balwinder Singh Sandhu, Milind Rege and Ajit Agarkar were also present at the condolence meeting. (ANI)

Archaeologists discover gemstone carrying portrait of Alexander the Great

Washington, September 16 (ANI): An archaeological team, during excavations in Israel, has discovered a gemstone that has a portrait of Alexander the Great engraved on it.

The excavations at Tel Dor were carried out by an archaeological team, which was directed by Dr. Ayelet Gilboa of the University of Haifa and Dr. Ilan Sharon of the Hebrew University of Jerusalem.

“Despite its miniature dimensions – the stone is less than a centimeter high and its width is less than half a centimeter – the engraver was able to depict the bust of Alexander on the gem without omitting any of the ruler’s characteristics,” said Dr. Gilboa, Chair of the Department of Archaeology at the University of Haifa.

“The emperor is portrayed as young and forceful, with a strong chin, straight nose and long curly hair held in place by a diadem,” he added.

The Tel Dor researchers have noted that it is surprising that a work of art such as this would be found in Israel, on the periphery of the Hellenistic world.

“It is generally assumed that the master artists – such as the one who engraved the image of Alexander on this particular gemstone – were mainly employed by the leading Hellenistic courts in the capital cities, such as those in Alexandria in Egypt and Seleucia in Syria,” according to the researchers.

“This new discovery is evidence that local elites in secondary centers, such as Tel Dor, appreciated superior objects of art and could afford ownership of such items,” they added.

The significance of the discovery at Dor is in the gemstone being uncovered in an orderly excavation, in a proper context of the Hellenistic period.

This tiny gem was unearthed by a volunteer during excavation of a public structure from the Hellenistic period in the south of Tel Dor, excavated by a team from the University of Washington at Seattle headed by Prof. Sarah Stroup.

Dr. Jessica Nitschke, professor of classical archaeology at Georgetown University in Washington DC, identified the engraved motif as a bust of Alexander the Great.

This has been confirmed by Prof. Andrew Stewart of the University of California at Berkeley, an expert on images of Alexander and author of a book on this topic.

Alexander was probably the first Greek to commission artists to depict his image – as part of a personality cult that was transformed into a propaganda tool. (ANI)

Ancient book of Buddhism chantings found in Korean temple

Seoul, September 16 (ANI): Archaeologists have uncovered an ancient Chinese book of Buddhism chantings in a Korean temple.

According to a report in Korea Times, the Hangeul copy of an ancient Chinese book, which contains the notes of the Joseon Kingdom (1392-1910) scholar Kim Si-seup, was discovered at Baekryunam, Haein Temple.

The book was originally written by a Buddhist master from the Tang Dynasty (618-907) and dates back to the 16th century.

“We discovered the ‘shiphyeondam eonhaebon’ while we were examining the library of Ven. Seong Cheol (1912-1993) at Baekryunam, Haein Temple, in April this year,” Ven. Won Taek said at a press conference at the Jogye Order, northern Seoul.

“It’s a rare book ? perhaps even the only copy ? that is not included in the Natural Treasures list nor on the lists of national libraries and university libraries,” he said.

An eonhae copy, or eonhaebon, is a book or writing that contains the literal translation of a sentence in Chinese to Hangeul, or Korean.

It is different from the normal translation books as it features a word-for-word translation, and is far removed from the Hangeul sentences used today.

‘Shiphyeondam’ refers to the 10 songs and poems made to praise Buddha’s teachings, written by Tang Dynasty Buddhist master Dongan Sangchal of the Jodong Order of Zen Buddhism, a sect of the religion in China.

The songs are comprised of seven Chinese characters and contain the traditions and the practices of the Jodong Order.

Ven. Won Taek explained that the discovery was meaningful as the book was from the 16th century. Most of the eonhaebons known today are from the 15th century.

“We found many precious ancient books and eonhaebons while examining the library and we will apply these artifacts as Natural Treasures after examining the value of them. We will also make photo prints of the eonhaebons for ancient hangeul and writing experts to use them as research material,” he said. (ANI)

Master gene that switches on disease-fighting cells identified

London, Sep 14 (ANI): British scientists have identified the master gene, called E4bp4, that causes blood stem cells to turn into disease-fighting ‘Natural Killer’ (NK) immune cells.

The discovery, by researchers at Imperial College London, UCL and the Medical Research Council’s National Institute for Medical Research, could one day help scientists boost the body’s production of these frontline tumour-killing cells, creating new ways to treat cancer.

By ‘knocking out’ E4bp4 in a mouse model, the researchers created the world’s first animal model entirely lacking NK cells, but with all other blood cells and immune cells intact.

The breakthrough model should help solve the mystery of the role that Natural Killer cells play in autoimmune diseases, such as diabetes and multiple sclerosis.

According to many scientists, these diseases are a result of malfunctioning NK cells that turn on the body and attack healthy cells, which cause disease instead of fighting it.

They believe that clarifying NK cells’ role could lead to new ways of treating these conditions.

Natural Killer cells – a type of white blood cell – are a major component of the human body’s innate, quick-response immune system, providing a fast frontline defence against tumours, viruses and bacterial infections.

The gene E4bp4 is the ‘master gene’ for NK cell production, which means it is the primary driver that causes blood stem cells in the bone marrow to differentiate into NK cells.

Led by Dr Hugh Brady, the researchers are hoping to progress with a drug treatment for cancer patients which reacts with the protein expressed by their E4bp4 gene, causing their bodies to produce a higher number of NK cells than normal, to increase the chances of successfully destroying tumours.

“If increased numbers of the patient’s own blood stem cells could be coerced into differentiating into NK cells, via drug treatment, we would be able to bolster the body’s cancer-fighting force, without having to deal with the problems of donor incompatibility,” Nature quoted Brady as saying.

The researchers proved the pivotal role E4bp4 plays in NK production when they knocked the gene out in a mouse model.

Without E4bp4 the mouse produced no NK cells whatsoever but other types of blood cell were unaffected.

“Now finally, with our discovery of the NK cell master gene and subsequent creation of our mouse model, we will be able to find out if the progression of these diseases is impeded or aided by the removal of NK cells from the equation. This will solve the often-debated question of whether NK cells are always the ‘good guys’, or if in certain circumstances they cause more harm than good,” said Brady.

The study has been published in Nature Immunology. (ANI)

Pet dog in China can bolt, unbolt door with front legs!

New Delhi, Sep 9 (ANI): A pet dog in China apparently posses extraordinary skills, for it can bolt and unbolt doors with its front legs.

The dog, belonging to a family in Ningxiang county of Hunan province, has become the neighbourhood star, reports the China Daily.

Li Guiping, the owner of the dog, named Hu Zi, said that his pet was able to perform the stunt after only being showed a handful of times.

On the orders of its master, Hu Zi stands on its hind legs and bolts or unbolts the door lock with its front legs. (ANI)

Turning off oncogene may inhibit lung cancer stem cells’ growth

Washington, Sep 9 (ANI): A lung cancer oncogene, called PKCiota, is necessary for the proliferation of lung cancer stem cells, and turning it off could act as a key for the treatment of this deadly disease, according to scientists at the Mayo Clinic campus in Florida.

These stem cells are rare and powerful master cells that manufacture the other cells that make up lung tumours, and are resistant to chemotherapy treatment.

The study also shows that an agent, aurothiomalate, being tested at Mayo Clinic in a phase I clinical trial substantially inhibits growth of these cancer stem cells.

“Our data indicate that PKCiota is required for the earliest steps in the development of lung cancer, which is the expansion of tumor-initiating cells or cancer stem cells,” said the study’s senior author, Dr. Alan Fields.

“Lung cancer stem cells appear to be the major drivers in many common lung cancers, and in order for a therapeutic treatment to be effective, it has to disrupt these cancer stem cells. We show that aurothiomalate, the agent now being tested in lung cancer patients, can, in fact, target these cells,” he added.

While aurothiomalate was once used to treat rheumatoid arthritis, the researchers have now discovered that it can also target PKCiota.

Currently, the agent is being tested in patients at Mayo Clinic’s sites in Minnesota and Arizona and, based on this phase I trial, a phase II human clinical trial is planned to combine aurothiomalate with agents targeted at other molecules involved in cancer growth.

“We had previously shown that PKCiota is required to maintain tumor growth, but what this study sought to determine is whether PKCiota is involved in the initial steps of lung cancer development,” said Fields.

Fields said that, in mice, an oncogene known as Kras is thought to transform normal lung stem cells into cancer stem cells, thereby initiating lung cancer.

In the present study, the researchers established a strain of mice in which Kras can be activated at the same time that the PKCiota gene is inactivated.

They found that when the PKCiota gene is inactivated, Kras was unable to cause errant growth and expansion of lung stem cells in mice, the process that initiates tumour formation.

“What this told us is that Kras requires PKCiota to transform the lung stem cells and make them proliferate. In other words, PKCiota is downstream from Kras, and is necessary for Kras to initiate lung tumor formation,” said Fields.

After discovering that aurothiomalate disables PKCiota, the researchers tested whether this agent is effective against lung cancer that develops due to Kras mutation.

“The drug showed potent inhibitory effects on the Kras-dependent proliferation of lung cancer stem cells both in cell culture and in animals,” said Fields.

“That further suggests that a drug like aurothiomalate could have an effect on tumors that are dependent on either Kras or PKCiota for growth and survival, and that is potentially a lot of cancers.

Aurothiomalate appears to be one of the few drugs available that can effectively target these critical cancer stem cells. In the clinic, however, it is likely that aurothiomalate will be most effective when combined with other agents designed to target other tumor survival pathways,” he added.

The study has been published in Cancer Research. (ANI)

‘Master switch’ gene may help control obesity

Washington, Sept 4 (ANI): Scientists from University of Michigan claim to have discovered a gene, which when switched off, can control obesity in mice and help them remain thin.

According to Alan Saltiel, the Mary Sue Coleman Director of the U-M Life Sciences Institute, deleting the gene, called IKKE, appears to protect mice against conditions that, in humans, lead to Type 2 diabetes, which is associated with obesity.

He said that if follow-up studies confirm IKKE is tied to obesity in humans, the gene and the protein it will be prime targets for the development of drugs to treat obesity and diabetes.

“We’ve studied other genes associated with obesity – we call them ‘obesogenes’ – but this is the first one we’ve found that, when deleted, stops the animal from gaining weight,” said Saltiel, senior author of a paper.

“The fact that you can disrupt all the effects of a high-fat diet by deleting this one gene in mice is pretty interesting and surprising,” Saltiel added.

During the study, the high-fat-diet mice were fed a lard-like substance with 45 percent of its calories from fat. Control mice were fed standard chow with 4.5 percent of its calories from fat.

The gene IKKE produces a protein kinase also known as IKKE. The IKKE protein kinase appears to target proteins, which, in turn, control genes that regulate the mouse metabolism.

When the high-fat diet is fed to a normal mouse, IKKE protein-kinase levels rise, the metabolic rate slows, and the animal gains weight. In that situation, the IKKE protein kinase acts as a brake on the metabolism.

The new study showed that knockout mice placed on the high-fat diet did not gain weight, apparently because deleting the IKKE gene releases the metabolic brake, allowing it to speed up and burn more calories, instead of storing those calories as fat.

The new study is published in the journal Cell. (ANI)

How birds and mammals evolved to have 4-chambered hearts

Washington, Sep 3 (ANI): Scientists have discovered the first genetic link that can explain how the heart evolved from being a three-chambered to four-chambered organ.

The discovery has shed light on how cold-blooded birds and mammals became warm-blooded.

Frogs have a three-chambered heart consisting of two atria and one ventricle, which sends a concoction of blood that is not fully oxygenated to the rest of the frog’s body.

On the other hand, turtles’ hearts have three chambers, but the single ventricle starts developing a wall, or septum, which makes the heart send blood that is slightly richer in oxygen than the frog’s.

However, birds and mammals have a fully septated ventricle-a bona fide four-chambered heart, which ensures the separation of low-pressure circulation to the lungs, and high-pressure pumping into the rest of the body.

As warm-blooded animals, we use a lot of energy and therefore need a great supply of oxygen for our activities. The four-chambered heart gives us an evolutionary advantage- we’re able to roam, hunt and hide even in the cold of night, or the chill of winter.

But many humans suffer from congenital heart disease, a very common birth defect, which is usually caused by VSD, or ventricular septum defects-a condition that is frequently correctable with surgery

Benoit Bruneau of the Gladstone Institute of Cardiovascular Disease, who studies the transcription factor, Tbx5, in early stages of embryological development, has called it “a master regulator of the heart.”

He teamed up with scientists at Michigan State University to examine a wide evolutionary spectrum of animals and found that in the cold-blooded, Tbx5 is expressed uniformly throughout the forming heart’s wall.

On the other hand, warm-blooded embryos showed the protein very clearly restricted to the left side of the ventricle, which allowed for the separation between right and left ventricle.

Interestingly, in the turtle, the molecular signature was found to be transitional as well.

A higher concentration of Tbx5 is found on the left side of the heart, gradually dissipating towards the right.

“The great thing about looking backwards like we’ve done with reptilian evolution is that it gives us a really good handle on how we can now look forward and try to understand how a protein like Tbx5 is involved in forming the heart and how in the case of congenital heart disease its function is impaired,” concluded Bruneau. (ANI)

Meet the dog that walks on its hind legs like a kangaroo!

New Delhi, Aug 31 (ANI): A dog in China walks on its two rear legs like a kangaroo.

Jiang Siquan, a senior citizen who resides in Chongqing, has trained his pet dog “Chou Chou” to stroll on its back legs, reports the China Daily.

The senior citizen apparently trained his 2-year-old dog for more than a month to make it walk on its hind legs,

Chou Chou goes for a stroll with its master every morning. (ANI)

Molecule having anti-fat, anti-cancer abilities found to be a turnoff for fat genes

Washington, Aug 28 (ANI): Researchers at Baylor College of Medicine have found that a small molecule, earlier found to have anti-fat and anti-cancer abilities, has the potential to put off fat-making genes.

Such action in mice genetically prone to obesity causes the animals to become leaner, they say.

The researchers have also found the molecule to lowers the amount of fat in the mice’s livers, along with their blood sugar and cholesterol levels.

“We are frankly very excited about it. It goes to the origin of [fat synthesis] – all the way back to gene expression,” said Salih Wakil at Baylor.

Unlike cholesterol-lowering statins in use today, which block a single enzyme in the pathway, the chemical the researchers call fatostatin, “hits fat from the very beginning,” said Motonari Uesugi.

As a result, fatostatin influences many of the genes involved in fat production and in various aspects of metabolic syndrome – a collection of risk factors including obesity, high cholesterol and insulin resistance – in one go.

Studies in cell culture showed that fatostatin, previously known only as 125B11, significantly lowers the activity of 63 genes, including 34 directly associated with fatty acid or cholesterol synthesis.

Many of these genes were known to be under the control of SREBP – a transcription factor which act as a well-known master controller of fat synthesis.

After more detailed analysis, the researchers found that the drug candidate blocked SREBP by preventing it from becoming active and entering the nucleus, where it would otherwise switch on the fat-making program.

According to them, it operates by binding another protein (called SCAP), which serves as SREBP’s escort into the nucleus.

It was found that obese mice injected with fatostatin show noticeable reductions in their weight despite little difference in their eating habits, the researchers report.

After four weeks of treatment, the animals weighed 12 percent less and had 70 percent lower blood sugar levels.

Their cholesterol levels (both LDL and HDL) were down too. The concentration of fatty acids in their blood was actually higher- a sign of their greater demand for fat to burn.

While the livers of the obese mice were heavy and pale with fat, treated animals’ livers were more than 30 percent lighter and were a healthy-looking red.

Although less obvious, the SREBP-blocking ability might also explain the molecule’s earlier reported effects against prostate cancer cells in culture as well.

They explained that cells need fatty acids and cholesterol to build their cell membranes and continue growing.

Researchers are optimistic that fatostatin could prove to be clinically useful in the context of obesity, and perhaps cardiovascular disease and diabetes as well.

“Hopefully down the road, fatostatin or a derivative of fatostatin may be helpful. It could have a broad impact on the key diseases we all suffer from,” said Wakil.

Uesugi said that fatostatin or its analogs may also serve a tool for gaining further insights into the regulation of SREBP and fat metabolism.

The study has been published in the journal Chemistry and Biology. (ANI)

Genetic discovery could pave way for obesity, diabetes treatments

Washington, Aug 27 (ANI): Researchers at University of Central Florida have identified a new genetic mechanism that controls the body’s fat-building process, paving way for treatments for obesity and type 2 diabetes.

The discovery has the potential to help hundreds of millions of people and dramatically cut health care costs.

Led by Pappachan Kolattukudy, director of UCF’s Burnett School of Biomedical Sciences in the College of Medicine, found that a gene called MCPIP (Monocyte Chemotactic Protein-1 Induced Protein) controls the development of fat cells.

Until now, a different protein, known as peroxisome proliferator-activated receptor gamma (PPAR gamma), has been universally accepted as the master controller of fat cell formation, known as adipogenesis.

But the new findings has opened new doors for scientists looking forward to develop drugs that could benefit the more than 300 million people worldwide who are clinically obese, and who have much higher risks of suffering from chronic disease and disability.

Besides, it is projected that more than 300 million people will be diabetic by the year 2025.

Kolattukudy said MCPIP is potentially an ideal target for drugs that would prevent the body from becoming resistant to insulin and prone to type 2 diabetes.

“Our research has shown that MCPIP is a regulator of fat cell formation and blood vessel formation that feeds the growing fat tissue. Therefore, a drug that can shut down its function can prevent obesity and the major inflammatory diseases resulting from obesity, including diabetes and cardiovascular diseases,” the expert said.

For the study, the researchers introduced MCPIP to living cells from mice that had been stripped of the PPAR gamma gene and found that the cells still completed the developmental process necessary to build fat.

Now, the researchers are planning to explore chemical combinations to discover drugs that are effective at shutting down the novel gene.

The development of new drugs that can block or slow down the formation of MCPIP likely would take several years.

The findings will be published in the October issue of the Journal of Biological Chemistry. (ANI)

BJP announces list for assembly by elections

New Delhi, Aug 22 (ANI): The Bharatiya Janata Party (BJP) on Saturday announced the list of candidates to the by elections to be held at four states of Bihar, Delhi, Gujarat and Madhya Pradesh.

Party General Secretary Ananth Kumar released the list of 11 candidates to the media in the national capital.

Kumar said party’s central election committee has authorized party president Rajnath Singh to decide the candidates for remaining six seats of Bodha Gaya, Begusarai, Aurai, and Bihar, Tendukeva in Madhya Pradesh and Jasden and Danta in Gujarat.

The BJP nominated party’s Minority Morcha National Secretary Mohd Irfan Ahmed for the Ohkhla seat in Delhi State Assembly.

The list stated:

Delhi – Dwaraka _ Pradyumna Singh Rajput, Okhla – Mohmd Irfan hmed

Bihar: Wahishwar Nagar (Reserve) Sanjay Paswan, Ramgarsh – Abhay ingh, Chinpur-Brij Kishore Bind,

Gujarat : Dhoraji – Jaisukhbhai Tesia, Kodihar- Natwar Singh Wala, Chotila-Varshmbhai Khurani, Sami -Bhairosingh Rathore, Dehagaon – Kalyan Singh Chouhan,

Madhya Pradesh Gohad- Sur Jatav Master (ANI)

New X-ray technique reveals buried image in N. C. Wyeth’s painting

Washington, August 20 (ANI): A new X-ray imaging technique has for the first time in a century revealed unprecedented details of a painting hidden beneath another painting by famed American illustrator Newell Convers Wyeth, who is regarded as the greatest American illustrator of the 20th century.

While making a presentation at the 238th National Meeting of the American Chemical Society (ACS) on Wednesday, Dr. Jennifer Mass said that the non-destructive look-beneath-the-surface method could reveal hidden images in hundreds of Old Master paintings, and other prized works of art.

In the study paper, the researcher noted that many great artists re-used canvases or covered paintings with other paintings, in order to save money on materials or to let the colours and shapes of a prior composition influence the next one.

Art historians believe that several of Wyeth’s most valued illustrations have been lost from view in that way, and one of them, depicting a dramatic fist fight, was published in a 1919 Everybody’s Magazine article titled ‘The Mildest Mannered Man’.

X-ray techniques previously used by other scientists suggested that Wyeth had covered the fight scene with another painting called ‘Family Portrait’, but they had not shown the the true image except in black and white reproductions.

The new instrument, called a confocal X-ray fluorescence microscope, was developed at the Cornell High Energy Synchrotron Source (CHESS) national X-ray facility.

The instrument reveals minute details in hidden paintings without removing paint samples. It shoots X-ray beams into a painting and then collects fluorescent X-ray “signals” given off by the chemicals in the various paint layers.

Scientists can link each signal to specific paint pigments.

In addition to revealing the original image, the method is providing new information on Wyeth’s materials and methods.

The same technique may ultimately reveal hidden images in paintings by other famed artists, the researchers say. (ANI)

Pocket watch found off Welsh coast returned- after 130 years!

London, Aug 19 (ANI): A silver pocket watch, which was lost 130 years ago, has finally being returned to the family of its owner.

The watch belonging to one Captain Richard Prichard lay at the bottom of the ocean for over a century.

Rich Hughes, a diver, spotted the watch in the sand as he explored a shipwreck sunk off the Welsh coast.

After bringing it to the surface, he saw the words “Richard Prichard 1866 Abersoch North Wales” engraved on the casing and set out in search of the family.

“I was amazed that the watch was in such good condition after laying at the bottom of the sea for generations,” the Telegraph quoted Hughes, 38, as saying.

“As soon as I saw the name it started me thinking about Richard Prichard.

“I knew he would be the master and commander of the ship – none of the crew would be able to afford a valuable timepiece,” he added.

Hughes discovered Prichard was the captain of the Barbara, a square-rigged barque which came to grief during a storm off the Pembrokeshire coast in 1881. He had mysteriously died earlier during the voyage to pick up a cargo of rice from Burma.

He was buried at sea and a new master, known only as Captain Jones, became the watch’s custodian – probably intending to give it to the Prichard family after arriving in Liverpool.

However, the vessel was hit by a storm and the Barbara sank off the village of Freshwater West, Pembrokeshire, in November 1881.

Hughes, of Fishguard, Pembrokeshire, used the internet to scan old manuals and shipping records and also took help of amateur historian David Roberts to trace Capt Prichard’s family.

The watch will be handed to retired dentist Owen Cowell, of Pwllheli, North Wales later this month.

Cowell’s grandmother was Captain Prichard’s cousin, making him the closest surviving family member.

“I am delighted the watch has come home after all these years,” said Cowell.

“It has come as a complete surprise to me that my ancestors had such a colourful, seafaring past,” he added. (ANI)

Visually impaired bamboo artist enables others for self-reliance

Gangtok, July 15 (ANI): A visually impaired bamboo artisan in Sikkim imparts training to many other disadvantaged people like him and help them gain self-reliance in life.

The 37-year-old Chandra Singh Gurung is one of the visually challenged workers offering training to enthusiastic artists under Directorate of handloom and industry in Cane and Bamboo crafts.

Gurung is a master bamboo and cane artist. He has been working in the bamboo and cane unit of the Directorate of Handicrafts and Handlooms for over a decade and has set an example of self-reliance.

The principal handicrafts of the region include basketwork, cane furniture, bamboo flower, mats and woodcarvings. The items which are made include stools, flowers, pen stands, picture frames, baskets, dust bins, beer mugs, hair clips and butterfly wall decoration.

Having learnt the art of Moda making (cane or bamboo stools) at the Kalimpong Salvation Army Institution, the Braille matriculate Gurung joined the Directorate as an artisan in 1986.

He tells that Government has opened many schemes for the people like him where they could learn the art as per their talent.

“Indian Government has opened many schemes for the people like us. I’m doing this cane and bamboo work in Sikkim. Others can go in for light engineering while still others can take up physiotherapy as per their talent,” said Gurung.

Every ‘moda’ Gurung makes sells at anything between 9.24 dollars to 10.27 dollars a piece.

Gurung is today not just a worker but a trainer as well and has trained jail inmates at the state prison in Rongyek, near Gangtok.

Namrata Thapa, directorate of Handicraft and Handloom Industry, Sikkim said that in this institute the students could earn while they learnt.

“This is the institute where we are providing employment opportunities to the physically handicapped people as far as possible not only the employment opportunities but we are giving them training in different crafts also as per their aptitude in their fields that they are interested to pursue,” said Thapa. By Tashi Pradhan(ANI)

Presence of neo-Nazis once again haunts US military

Atlanta, July 13 (ANI): The latest revelation on the appearance of at least 40 active-duty US soldiers on a neo-Nazi social networking website has confirmed the controversial government report released in April about the growing presence of white supremacy in the military.

According to the disclosure by the Southern Poverty Law Center, there were at least 40 profiles related to active-duty military members on NewSaxon.org, known as the “fascist Facebook,” csmonitor.com reports.

“I love and will do anything to keep our master race marching,” writes “WhitePride85,” who claims on the site to be a 24-year-old staff sergeant from Madison, Wis.

The civil rights organization, which delivered its report to the House and Senate Armed Services and Homeland Security Committees on Monday, raised new questions about how serious the Army is about rooting out rank-and-file neo-Nazis.

“There are many people in the military using new technology to put up racist profiles, racist music and books that they love that are racist, and as the regulations stand today that’s not grounds for being tossed out of the military,” SPLC spokeswoman Heidi Beirich said.

Undersecretary of Defense David Chu, however, told the SPLC that the Army has zero tolerance for racists in the ranks.

Jeffrey Castro, a spokesman for the Army’s Criminal Investigation Command at Fort Belvoir, Va., said his command investigates supremacist leanings only in relation to felony accusations. “Being a gang member, for instance is not a felony-level crime.”

It’s the unit commander who determines whether a soldier a neo-Nazi, and the Army policy states that commanders cannot, however, dismiss them.

In 2007, the FBI reported on concern about white supremacists recruiting soldiers, saying “hundreds” of neo-Nazis were in the active military.

Such groups hope to utilize their combat skills in “a coming race war,” says former marine TJ Leyden, an ex-white supremacist and author of “Skinhead Confessions.” (ANI)

N.L. Dalmia ~ N.L. Dalmia College ~ N.L. Dalmia MBA College Mumbai at nldalmiamgmt.org

N.L. Dalmia ~ N.L. Dalmia College ~ N.L. Dalmia MBA College Mumbai at nldalmiamgmt.org

N. L. Dalmia Institute of Management Studies and Research (N. L. Dalmia) was formed under the aegis of N. L. Dalmia Educational Society. Late Shri. Niranjanlal Dalmia, a visionary, philanthropist and industrialist is the founder chairman of the society. N. L. Dalmia

Established in 1995, N. L. Dalmia commenced its academic programs in July 1997, offering Master’s in Management Studies (MMS), a two year full-time course affiliated to the University of Mumbai and three year Part-time Post Graduate Diploma in Business Management approved by AICTE.

The Institute also has its esteemed Post Graduate Diploma in Business Management (PGDBM), a two year full-time course approved by AICTE.

In the year 2003, the Institute commenced three year Part-time Programs (MMM, MFM and MHRDM) affiliated to the University of Mumbai.

Visit NL Dalmia Management College, Mumbai website www.nldalmiamgmt.org for information on courses offered, Admission dates & results and latest News & Events at the MBA Institute.

NL Dalmia Management College Website – http://nldalmiamgmt.org/

How practice improves zebra finch’s singing performance

Washington, July 7 (ANI): A study on zebra finches conducted by neuroscientists at the Massachusetts Institute of Technology (MIT) has shed some light on how practice improves performance.

The researchers say that studying the chirps of zebra finches helped them determine that as these tiny songbirds fine-tune their songs, their brains initially store improvements in one brain pathway, before transferring this learned information to the motor pathway for long-term storage.

They believe that their findings may further scientists’ understanding of the complicated circuitry of the basal ganglia, brain structures that play a key role in learning and habit formation in humans.

The basal ganglia are also linked to disorders like Parkinson’s disease, obsessive-compulsive disorder and drug addiction.

“Birds provide a great system to study the fundamental mechanisms of how the basal ganglia contributes to learning. Our results support the idea that the basal ganglia are the gateway through which newly acquired information affects our actions,” said senior author Michale Fee, an investigator in the McGovern Institute for Brain Research at MIT.

The researchers point out that young zebra finches learn to sing by mimicking their fathers, whose song contains multiple syllables in a particular sequence.

Like the babbling of human babies, young birds initially produce a disorganized stream of tones, but after practicing thousands of times they master the syllables and rhythms of their father’s song.

Studies conducted in the past have identified two distinct brain circuits that contribute to this behaviour in zebra flinches.

A motor pathway is responsible for producing the song, and a separate pathway is essential for learning to imitate the father. The learning pathway, called the anterior forebrain pathway (AFP), has similarities to basal ganglia circuits in humans.

“For this study, we wanted to know how these two pathways work together as the bird is learning. So we trained the birds to learn a new variation in their song and then we inactivated the AFP circuit to see how it was contributing to the learning,” said first author Aaron Andalman, a graduate student in Fee’s lab.

With a view to training the birds, the research team monitored their singing and delivered white noise whenever a bird sang a particular syllable at a lower pitch than usual.

“The bird hears this unexpected noise, thinks it made a ‘mistake’, and on future attempts gradually adjusts the pitch of that syllable upward to avoid repeating that error. Over many days we can train the bird to move the pitch of the syllable up and down the musical scale,” Fee said.

On a particular day, after four hours of training in which the birds learned to raise the pitch, the researchers temporarily inactivated the AFP with a drug. The pitch immediately slipped back to where it had been at the start of that day’s training session – suggesting that the recently learned changes were stored within the AFP.

The research group, however, observed that over the course of 24 hours, the brain had transferred the newly learned information from the AFP to the motor pathway. The motor pathway was storing all of the accumulated pitch changes from previous training sessions. (ANI)

Indian-origin scientist finds genetic switch that may help treat vascular diseases

London, July 6 (ANI): Taking a big leap towards finding a treatment of vascular diseases, a team led by an Indian-origin scientist at the Gladstone Institute of Cardiovascular Disease (GICD) has discovered a key switch that makes stem cells turn into the type of muscle cells that reside in the wall of blood vessels.

Dr. Deepak Srivastava’s study claimed that the same switch could be used in the future to limit growth of vascular muscle cells that cause narrowing of arteries leading to heart attacks and strokes, limit formation of blood vessels that feed cancers, or make new blood vessels for organs that are not getting enough blood flow.

It was found that a tiny RNA molecule, called microRNA-145 (miR-145), not only had all the information necessary to turn a stem cell into a vascular smooth muscle cell (VSMC), but could also affect VSMCs in the adult artery.

VSMCs possess the unique property of dividing on their own when an artery is injured or during atherosclerosis, ultimately causing narrowing of the vessel leading to occlusion.

The researchers found that miR-145 and its sister microRNA, miR-143, work together to stop the pathologic division of VSMCs.

But in the setting of vessel disease, their activity was turned down, which made the VSMCs to divide and clog up the artery.

MicroRNAs are small RNA molecules that do not make protein, but instead affect that amount of protein synthesized by the cell from their target mRNAs-the blueprints for translating the genetic code into proteins.

The researchers found that miR-145 and miR-143 together controlled the synthesis of a network of “master regulators” that control VSMCs, and thereby were able to function as a central “switch” for the behaviour of these important cells.

“The ability of miR-145 to efficiently direct the cell fate of vascular smooth muscle cells from stem cells represents the power of these tiny microRNAs to exert major effects on cells. We hope that we can use this knowledge to control when the body makes or does not make new blood vessels,” Nature magazine quoted Srivastava as saying.

He added: “Our findings in this study offer insights into regulatory mechanisms that govern the differentiation and proliferation of smooth muscle. They have fundamental implications for the treatment of vessel diseases like atherosclerosis and also may be important for cancer.”

The study has been published in the current issue of the journal Nature. (ANI)